Abbas Dehghan

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study
    Abbas Dehghan
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    BMC Med 6:30. 2008
  2. ncbi Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study
    Mandy van Hoek
    Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
    Diabetes 57:3122-8. 2008
  3. ncbi SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin
    M Carola Zillikens
    Department of Internal Medicine, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
    Free Radic Biol Med 46:836-41. 2009
  4. ncbi Risk of type 2 diabetes attributable to C-reactive protein and other risk factors
    Abbas Dehghan
    Department of Epidemiology and Biostatistics, Erasmus Medical Center, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Diabetes Care 30:2695-9. 2007
  5. ncbi Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
    Abbas Dehghan
    Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands
    Lancet 372:1953-61. 2008
  6. ncbi High serum uric acid as a novel risk factor for type 2 diabetes
    Abbas Dehghan
    Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, P O Box 2040, 3000 CA Rotterdam, Netherlands
    Diabetes Care 31:361-2. 2008
  7. ncbi Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels
    Abbas Dehghan
    Erasmus Medical Center, Dr Molewaterplein 50, Rotterdam, Netherlands
    Circulation 123:731-8. 2011
  8. ncbi Genetic variation, C-reactive protein levels, and incidence of diabetes
    Abbas Dehghan
    Department of Epidemiology and Biostatistics, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
    Diabetes 56:872-8. 2007
  9. ncbi Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts
    Abbas Dehghan
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Circ Cardiovasc Genet 2:125-33. 2009
  10. ncbi Low-risk susceptibility alleles in 40 human breast cancer cell lines
    Muhammad Riaz
    Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands
    BMC Cancer 9:236. 2009

Detail Information

Publications13

  1. ncbi Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study
    Abbas Dehghan
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    BMC Med 6:30. 2008
    ..We examined the SNPs in relation to the risk of CHD and MI in a large population based study of elderly population...
  2. ncbi Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study
    Mandy van Hoek
    Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands
    Diabetes 57:3122-8. 2008
    ..Genome-wide association (GWA) studies identified multiple new genetic variants that associate with type 2 diabetes. The predictive value of genetic testing for prediction of type 2 diabetes in the general population is unclear...
  3. ncbi SIRT1 genetic variation and mortality in type 2 diabetes: interaction with smoking and dietary niacin
    M Carola Zillikens
    Department of Internal Medicine, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
    Free Radic Biol Med 46:836-41. 2009
    ..Correction of niacin deficiency and SIRT1 modulators may prolong the life span of patients with diabetes...
  4. ncbi Risk of type 2 diabetes attributable to C-reactive protein and other risk factors
    Abbas Dehghan
    Department of Epidemiology and Biostatistics, Erasmus Medical Center, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Diabetes Care 30:2695-9. 2007
    ..To calculate the population-attributable risk (PAR) of C-reactive protein (CRP) and other risk factors for type 2 diabetes...
  5. ncbi Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study
    Abbas Dehghan
    Department of Epidemiology, Erasmus Medical Centre, Rotterdam, Netherlands
    Lancet 372:1953-61. 2008
    ..Hyperuricaemia, a highly heritable trait, is a key risk factor for gout. We aimed to identify novel genes associated with serum uric acid concentration and gout...
  6. ncbi High serum uric acid as a novel risk factor for type 2 diabetes
    Abbas Dehghan
    Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, P O Box 2040, 3000 CA Rotterdam, Netherlands
    Diabetes Care 31:361-2. 2008
    ..To investigate the association between serum uric acid level and risk of type 2 diabetes...
  7. ncbi Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels
    Abbas Dehghan
    Erasmus Medical Center, Dr Molewaterplein 50, Rotterdam, Netherlands
    Circulation 123:731-8. 2011
    ..C-reactive protein (CRP) is a heritable marker of chronic inflammation that is strongly associated with cardiovascular disease. We sought to identify genetic variants that are associated with CRP levels...
  8. ncbi Genetic variation, C-reactive protein levels, and incidence of diabetes
    Abbas Dehghan
    Department of Epidemiology and Biostatistics, Erasmus Medical Center, 3000 CA Rotterdam, The Netherlands
    Diabetes 56:872-8. 2007
    ..45, 95% CI 1.08-1.96). These findings support the hypothesis that serum CRP enhances the development of diabetes...
  9. ncbi Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts
    Abbas Dehghan
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Circ Cardiovasc Genet 2:125-33. 2009
    ..Fibrinogen is both central to blood coagulation and an acute-phase reactant. We aimed to identify common variants influencing circulation fibrinogen levels...
  10. ncbi Low-risk susceptibility alleles in 40 human breast cancer cell lines
    Muhammad Riaz
    Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands
    BMC Cancer 9:236. 2009
    ..The mechanism by which the low-risk SNPs confer breast cancer risks is currently unclear. The breast cancer association consortium BCAC has hypothesized that the low-risk SNPs modulate expression levels of nearby located genes...
  11. ncbi Renal function is related to severity of coronary artery calcification in elderly persons: the Rotterdam study
    Abdelilah El Barzouhi
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    PLoS ONE 6:e16738. 2011
    ..Since renal function diminishes with aging we examined the association between GFR and CAC in the Rotterdam Study, a population-based study of elderly individuals...
  12. ncbi Blood pressure parameters and carotid intraplaque hemorrhage as measured by magnetic resonance imaging: The Rotterdam Study
    Mariana Selwaness
    Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
    Hypertension 61:76-81. 2013
    ..The association between pulsatile flow and IPH may provide novel insights in the development of the vulnerable plaque...
  13. ncbi Variance heterogeneity analysis for detection of potentially interacting genetic loci: method and its limitations
    Maksim V Struchalin
    Department of Epidemiology, Erasmus MC, Rotterdam, 3000 CA, The Netherlands
    BMC Genet 11:92. 2010
    ..In this work, we evaluated statistical properties of variance heterogeneity analysis in respect to the detection of potentially interacting SNPs in a case when an interaction variable is unknown...